In two mouse models (Angiotensin II-induced model and elastase-induced model), the specific knockout of BAF60a in VSMCs significantly reduced the incidence of AAA, while also reducing vascular inflammation, monocyte infiltration, elastin degradation, and extracellular matrix (ECM) degradation. The gene discussed is ELN; the disease is triple-A syndrome.